Cited by 5,054Epilepsy research and treatmentNeurology and Historical StudiesDiet and metabolism studies

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

Open access
Scheffer, Ingrid E., Berkovic, Samuel, Capovilla, Giuseppe, Connolly, Mary B., French, Jacqueline, Guilhoto, Laura, Hirsch, Edouard, Jain, Satish +8 more·2017·Epilepsia

Abstract

Summary: The International League Against Epilepsy ( ILAE ) Classification of the Epilepsies has been updated to reflect our gain in understanding of the epilepsies and their underlying mechanisms following the major scientific advances that have taken place since the last ratified classification in 1989. As a critical tool for the practicing clinician, epilepsy classification must be relevant and dynamic to changes in thinking, yet robust and translatable to all areas of the globe. Its primary purpose is for diagnosis of patients, but it is also critical for epilepsy research, development of antiepileptic therapies, and communication around the world. The new classification originates from a draft document submitted for public comments in 2013, which was revised to incorporate extensive feedback from the international epilepsy community over several rounds of consultation. It presents three levels, starting with seizure type , where it assumes that the patient is having epileptic seizures as defined by the new 2017 ILAE Seizure Classification. After diagnosis of the seizure type , the next step is diagnosis of epilepsy type , including focal epilepsy, generalized epilepsy, combined generalized, and focal epilepsy, and also an unknown epilepsy group. The third level is that of epilepsy syndrome , where a specific syndromic diagnosis can be made. The new classification incorporates etiology along each stage, emphasizing the need to consider etiology at each step of diagnosis, as it often carries significant treatment implications. Etiology is broken into six subgroups, selected because of their potential therapeutic consequences. New terminology is introduced such as developmental and epileptic encephalopathy. The term benign is replaced by the terms self‐limited and pharmacoresponsive, to be used where appropriate. It is hoped that this new framework will assist in improving epilepsy care and research in the 21st century.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.13709

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In 2017, the ILAE expanded the concept to a 'developmental and epileptic encephalopathy' owing to a growing recognition that the aetiology, whether genetic, structural or otherwise, often causes developmental impairment in its own right.

    “In 2017, the ILAE expanded this concept to a 'developmental and epileptic encephalopathy', owing to a growing recognition that the aetiology, whether genetic, structural or otherwise, often causes developmental impairment in its own right 2 .”

    From Developmental and epileptic encephalopathies (2024) · cites this paper as [2]

    The ‘Developmental and epileptic encephalopathies’ section (page unavailable) explicitly broadens the term because many severe genetic disorders cause developmental consequences independently of epileptic activity. It also mentions cortical malformations and acquired causes, but does not establish that structural or other aetiologies often cause developmental impairment in their own right. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Approximately 70% of patients with epilepsy can achieve seizure freedom with appropriate antiepileptic drug (AED) therapy.

    “While approximately 70% of patients can achieve seizure freedom with appropriate antiepileptic drug (AED) therapy”

    From Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis (2026) · cites this paper as [7]

    The ‘Self-limited and pharmacoresponsive’ section says that some epilepsy syndromes are likely to be controlled with appropriate antiepileptic therapy. It does not give a 70% figure or extend that likelihood to patients with epilepsy generally (searched: ‘70%’ and ‘seizure freedom’). The indexed passages provide no page numbers. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The remaining 30% of patients have drug-resistant epilepsy requiring consideration of surgical intervention, ketogenic dietary therapy, vagus nerve stimulation, or other neuromodulatory approaches.

    “the remaining 30% have drug-resistant epilepsy requiring consideration of surgical intervention, ketogenic dietary therapy, vagus nerve stimulation, or other neuromodulatory approaches6,7”

    From Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis (2026) · cites this paper as [7]

    In Classification of the Epilepsies > Etiology (page unavailable), the paper says epilepsy surgery should be considered for certain structural epilepsies if medical therapy fails. It does not give the claimed 30% figure or recommend ketogenic therapy, vagus nerve stimulation, or other neuromodulation for that group. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The Treatment Misinformation Risk Scale (TMRS) was developed based on established epilepsy clinical evidence, classification criteria, treatment guidelines, and emerging literature on health misinformation on social media.

    “with the scale developed based on established epilepsy clinical evidence, classification criteria, and treatment guidelines3,7,8,31,32 as well as emerging literature on health misinformation on social media”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [10]Fisher RS Cross JH French JA Operational classification of seizure types by the International League Against Epilepsy Epilepsia 2017 3 8 10.1111/epi.13671 [Epub ahead of print] 28276060 · DOI

Cited by

Sorted by citations

Authors
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., Nordli, D. R., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y., & Zuberi, S. M.
Affiliations
  • Royal Children's Hospital (AU)
  • The University of Melbourne (AU)
  • Azienda Ospedaliera Carlo Poma (IT)
  • University of British Columbia (CA)
  • NYU Langone Health (US)
  • Hospital Universitário da Universidade de São Paulo (BR)
  • University Hospital INSERM U 964 Strasbourg France
  • Indian Epilepsy Centre New Delhi India
  • University of California, Los Angeles (US)
  • Albert Einstein College of Medicine (US)
  • Children's Hospital Los Angeles (US)
  • University of Pavia (IT)
  • Karolinska Institutet (SE)
  • University of Calgary (CA)
  • Peking University First Hospital (CN)
  • Royal Hospital for Children (GB)
Corresponding author
Scheffer, Ingrid E.
Venue
Epilepsia
Publisher
Wiley
Published
2017-03-08
Volume
58
Issue
4
Pages
512-521
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2592509339
Cited by
5,054
References
60
Citations by year
2026: 450 · 2025: 615 · 2024: 627 · 2023: 612 · 2022: 653 · 2021: 701 · 2020: 582 · 2019: 425 · 2018: 278 · 2017: 97 · 2016: 3 · 2015: 1 · 2014: 1
FWCI
310.55
Type
journal article
Language
en
Open access
Locations
  • Epilepsia (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion)
Funders
  • Universidade Católica de Brasília
  • Eisai
  • GlaxoSmithKline
  • Division of Arctic Sciences
  • National Institutes of Health (NS43209, 1U54NS100064‐01, 1‐RO1‐NS43209)
  • Humanities Research Center, Rice University
  • CURE Childhood Cancer
  • U.S. Department of Defense (W81XWH‐13‐1‐0180)
  • March of Dimes Foundation
  • Novartis
  • Canadian Institutes of Health Research
  • Lundbeckfonden
  • Pfizer
  • Vertex Pharmaceuticals
  • National Institute of Neurological Disorders and Stroke
  • Epilepsy Research UK
  • University of California, Los Angeles
  • Sanofi
  • Takeda Pharmaceuticals U.S.A.
  • Fundação Bial
  • Stockholms Läns Landsting
  • Sunovion
  • Yorkhill Children’s Charity
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Neurology › Neurology and Historical Studies
  • Health Sciences › Medicine › Physiology › Diet and metabolism studies
Keywords
epilepsy classification, seizure types, epilepsy type, epilepsy etiology, developmental and epileptic encephalopathy, self-limited epilepsy, generalized epilepsy, focal epilepsy, epilepsy terminology
MeSH terms
Epilepsy, Humans, International Agencies, Terminology as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review